Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450].

Journal: Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer
Published:
Relevant Conditions

Lung Cancer